Tocilizumab in Methotrexate-Naïve Rheumatoid Arthritis – A Cost-Utility Model for Slovakia
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.2326
https://www.valueinhealthjournal.com/article/S1098-3015(15)04402-2/fulltext
Title :
Tocilizumab in Methotrexate-Naïve Rheumatoid Arthritis – A Cost-Utility Model for Slovakia
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)04402-2&doi=10.1016/j.jval.2015.09.2326
First page :
A648
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
1739